Korean J Radiol.  2013 Oct;14(5):797-800. 10.3348/kjr.2013.14.5.797.

Irreversible Electroporation of a Hepatocellular Carcinoma Lesion Adjacent to a Transjugular Intrahepatic Portosystemic Shunt Stent Graft

• Niessen C
• Jung EM
• Wohlgemuth WA
• Trabold B
• Haimerl M
• Schreyer A
• Stroszczynski C
• Wiggermann P

• KMID: 1711436
• DOI: http://doi.org/10.3348/kjr.2013.14.5.797

Abstract

We report in a 65-year-old man hepatocellular carcinoma adjacent to a transjugular intrahepatic portosystemic shunt stent-graft which was successfully treated with irreversible electroporation (IRE). IRE is a new non-thermal tissue ablation technique which uses electrical pulses to induce cell necrosis by irreversible membrane poration. IRE proved to be more advantageous in the ablation of perivascular tumor with little injury to the surrounding structures.

Keyword

Radiology, interventional; Catheter Ablation, radiofrequency; Carcinoma, hepatocellular; Liver neoplasms; Irreversible electroporation

MeSH Terms

Aged
Carcinoma, Hepatocellular/diagnosis/*surgery
Electroporation/*methods
Humans
Liver Neoplasms/diagnosis/*surgery
Magnetic Resonance Imaging
Male
*Portasystemic Shunt, Transjugular Intrahepatic
*Stents
Tomography, X-Ray Computed
Ultrasonography, Doppler

Reference

1. Yun BL, Lee JM, Baek JH, Kim SH, Lee JY, Han JK, et al. Radiofrequency ablation for treating liver metastases from a non-colorectal origin. Korean J Radiol. 2011; 12:579–587.

2. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg. 1998; 227:559–565.

3. Dupuy DE, Aswad B, Ng T. Irreversible electroporation in a Swine lung model. Cardiovasc Intervent Radiol. 2011; 34:391–395.

4. Lee EW, Loh CT, Kee ST. Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat. 2007; 6:287–294.

5. Deodhar A, Dickfeld T, Single GW, Hamilton WC Jr, Thornton RH, Sofocleous CT, et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am J Roentgenol. 2011; 196:W330–W335.

6. Kingham TP, Karkar AM, D'Angelica MI, Allen PJ, Dematteo RP, Getrajdman GI, et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg. 2012; 215:379–387.

7. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005; 42:1208–1236.

8. Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2009; 49:453–459.

9. Kamusella P, Wiggermann P, Wissgott C, Andresen R, Stroszczynski C. [Thermal protection of targeted air instillation in CT-guided radiofrequency ablation]. Rofo. 2011; 183:952–955.

10. Raman SS, Lu DS, Vodopich DJ, Sayre J, Lassman C. Minimizing diaphragmatic injury during radio-frequency ablation: efficacy of subphrenic peritoneal saline injection in a porcine model. Radiology. 2002; 222:819–823.

11. Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012; 262:43–58.

12. Chang NK, Shin SS, Kim JW, Kim HJ, Jeong YY, Heo SH, et al. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization. Korean J Radiol. 2012; 13:Suppl 1. S104–S111.

13. Lee J, Lee JM, Yoon JH, Lee JY, Kim SH, Lee JE, et al. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas. Korean J Radiol. 2012; 13:34–43.